OpenAlex
PricingAboutJobs
Log inGet started
Work

Omarigliptin (MK-3102): A Novel Long-Acting DPP-4 Inhibitor for Once-Weekly Treatment of Type 2 Diabetes

HTML

Year: 2014
Type: other
Source: Journal of Medicinal Chemistry
DOI: 10.1021/jm401992e
Authors: Tesfaye Biftu, Ranabir Sinha-Roy, Ping Chen, Xiaoxia Qian, Dennis Feng, Jeffrey T. Kuethe, Giovanna Scapin, Ying Duo Gao, Youwei Yan, Davida Krueger, Annette Bak, George Eiermann, Jiafang He, Jason Cox, Jacqueline Hicks, Kathy Lyons, Huaibing He, Gino Salituro, Sharon Tong, Sangita Patel, George Doss, Aleksandr Petrov, Joseph Wu, Shiyao Sherrie Xu, Charles Sewall, Xiaoping Zhang, Bei Zhang, Nancy A. Thornberry, Ann E. Weber
Institution: Merck & Co., Inc., Rahway, NJ, USA (United States)
Language: English

Topic: Diabetes Treatment and Management
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Keywords: omarigliptin, DPP-4 inhibitors, dipeptidyl peptidase IV, type 2 diabetes, weekly dosing, mechanism of action, pharmacokinetics, medicinal chemistry, clinical development
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W2151185776
Cites: 19
Cited by: 182
Related to: 9
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms